Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Non-cash Items (2017 - 2026)

DiaMedica Therapeutics filings provide 10 years of Non-cash Items readings, the most recent being $16.8 million for Q1 2026.

  • Quarterly Non-cash Items rose 377.99% to $16.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $16.8 million through Mar 2026, up 377.99% year-over-year, with the annual reading at $10.6 million for FY2025, 3.49% up from the prior year.
  • Non-cash Items hit $16.8 million in Q1 2026 for DiaMedica Therapeutics, up from $10.6 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $21.2 million in Q3 2025 and bottomed at $462000.0 in Q3 2023.
  • Average Non-cash Items over 5 years is $6.1 million, with a median of $3.7 million recorded in 2023.
  • The largest annual shift saw Non-cash Items skyrocketed 4794.12% in 2022 before it plummeted 72.15% in 2024.
  • DiaMedica Therapeutics' Non-cash Items stood at $832000.0 in 2022, then changed by 0.0% to $832000.0 in 2023, then soared by 1131.13% to $10.2 million in 2024, then grew by 3.49% to $10.6 million in 2025, then surged by 58.59% to $16.8 million in 2026.
  • Per Business Quant, the three most recent readings for DMAC's Non-cash Items are $16.8 million (Q1 2026), $10.6 million (Q4 2025), and $21.2 million (Q3 2025).